全文获取类型
收费全文 | 7190篇 |
免费 | 673篇 |
国内免费 | 622篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 101篇 |
妇产科学 | 124篇 |
基础医学 | 835篇 |
口腔科学 | 115篇 |
临床医学 | 951篇 |
内科学 | 1066篇 |
皮肤病学 | 51篇 |
神经病学 | 358篇 |
特种医学 | 454篇 |
外国民族医学 | 4篇 |
外科学 | 699篇 |
综合类 | 1260篇 |
现状与发展 | 4篇 |
一般理论 | 3篇 |
预防医学 | 535篇 |
眼科学 | 154篇 |
药学 | 748篇 |
9篇 | |
中国医学 | 410篇 |
肿瘤学 | 560篇 |
出版年
2024年 | 10篇 |
2023年 | 101篇 |
2022年 | 168篇 |
2021年 | 354篇 |
2020年 | 273篇 |
2019年 | 224篇 |
2018年 | 218篇 |
2017年 | 193篇 |
2016年 | 215篇 |
2015年 | 320篇 |
2014年 | 393篇 |
2013年 | 309篇 |
2012年 | 503篇 |
2011年 | 574篇 |
2010年 | 375篇 |
2009年 | 283篇 |
2008年 | 343篇 |
2007年 | 432篇 |
2006年 | 380篇 |
2005年 | 423篇 |
2004年 | 304篇 |
2003年 | 271篇 |
2002年 | 269篇 |
2001年 | 225篇 |
2000年 | 247篇 |
1999年 | 199篇 |
1998年 | 126篇 |
1997年 | 128篇 |
1996年 | 108篇 |
1995年 | 82篇 |
1994年 | 86篇 |
1993年 | 50篇 |
1992年 | 59篇 |
1991年 | 48篇 |
1990年 | 44篇 |
1989年 | 30篇 |
1988年 | 28篇 |
1987年 | 16篇 |
1986年 | 20篇 |
1985年 | 11篇 |
1984年 | 9篇 |
1983年 | 14篇 |
1982年 | 3篇 |
1981年 | 6篇 |
1980年 | 2篇 |
1979年 | 5篇 |
1958年 | 2篇 |
1957年 | 2篇 |
排序方式: 共有8485条查询结果,搜索用时 15 毫秒
81.
本文观察了体外丙二醛(MDA),铜离子(Cu2+氧化修饰的脂蛋白(a)[Lp(a)]结构和生物学性质的变化。氧化修饰Lp(a)过氧化程度增高,负电荷增加,易被巨噬细胞—清道夫受体识别和摄取。MDA修饰Lp(a)出现新的MDA-LDL位点;同纤维蛋白溶酶原(Pg)竞争抑制试验显示氧化、修饰Lp(a)同Pg同源性增加。提示载脂蛋白(a)状态同动脉粥样硬化的病理过程有关。 相似文献
82.
He Z Dong Q Zhuang H Song S Peng G Luo G Dwyer DE 《Clinical and diagnostic laboratory immunology》2004,11(4):792-794
The sensitivities and specificities of an immunofluorescence assay and an enzyme immunoassay for detection of antibodies specific for severe acute respiratory syndrome coronavirus (SARS-CoV) were compared for 148 laboratory-confirmed SARS cases. The appearance and persistence of SARS-CoV-specific antibodies were assessed, with immunoglobulin G detected in 59% of samples collected within 14 days and persisting for 60 to 95 days after the onset of illness. 相似文献
83.
84.
Retrospective analysis of non-A-E hepatitis: possible role of hepatitis B and C virus infection 总被引:6,自引:0,他引:6
He Z Zhuang H Wang X Song S Dong Q Yan J Buehring GC Luo G 《Journal of medical virology》2003,69(1):59-65
In an effort to determine the cause of non-A-E hepatitis, a retrospective study was undertaken on a group of patients with hepatitis but without serological infection markers of hepatitis viruses A-E. A total of 60 patients admitted to Beijing Ditan Hospital during the period of September 1997 and September 1999 were chosen for this study. These patients were diagnosed as either acute or chronic hepatitis, but no serological markers of hepatitis viruses A-E were detected. Since TT virus (TTV), human parvovirus B19 (B19), SEN virus (SENV), and GB virus C/HGV were reported to be associated with hepatitis, attempts were made to detect the presence of these viruses in the sera of patients with non-A-E hepatitis by a nested polymerase chain reaction (nPCR) method. Also, more sensitive nPCR and RT-nPCR methods were used to determine HBV DNA and HCV RNA in these patients. Results derived from these analyses demonstrate that HBV DNA was detected in most of these patients (47/60, 78.3%), suggesting that HBV infection played a major role in occult non-A-E hepatitis and detection of HBV DNA by more sensitive PCR methods such as nPCR should be considered for diagnosis of HBV infection. In addition, HCV RNA was detected in three (5%) of these patients. However, GBV-C (HGV) RNA was not detected, and TTV, B19, and SENV appear not to be associated with non-A-E hepatitis, as the prevalence rates of these viruses in patients with non-A-E hepatitis were similar to those in patients with viral hepatitis A-E. The results from this study indicate that co-infection of TTV or B19 with HBV did not increase the severity of the disease. 相似文献
85.
方法:免疫细胞化学ABC法;目的:调查N-甲基-D-天冬氨酸型受体、磷酸激活的谷氨酰氨酶和谷氨酸在大鼠三叉神经尾侧亚核内的分布及其匹配关系.结果:N-甲基-D-天冬氨酸型受体1和2A/B亚单位免疫阳性胞体和纤维密集分布于大鼠三叉神经尾侧亚核的浅层(Ⅰ、Ⅱ层),磷酸激活的谷氨酰氨酶和谷氨酸免疫阳性胞体分布于三叉神经尾侧亚核各层,尤以浅层密集.磷酸激活的谷氨酸氨酶和谷氨酸阳性纤维及终未样结构主要分布于三叉神经尾侧亚核浅层.以上结果表明三叉神经尾侧亚核内磷酸激活的谷氨酰氨酶和谷氨酸免疫阳性纤维及终末样结构的分布与N-甲基-D-天冬氨酸型受体阳性胞体和纤维的分布在总体上是相互匹配的.结论:三叉神经尾侧亚核内的谷氨酸可能通过作用于N-甲基-D-天冬氨酸型受体的不同亚单位而发挥多种生理功能. 相似文献
86.
Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. 总被引:3,自引:2,他引:3 下载免费PDF全文
R. F. Chuaqui Z. Zhuang M. R. Emmert-Buck L. A. Liotta M. J. Merino 《The American journal of pathology》1997,150(1):297-303
Identical allelic loss in invasive and adjacent in situ ductal breast carcinoma (DCIS) on chromosome 11q13 has been previously reported, providing molecular evidence for the progression of DCIS to invasive tumor. In this study we analyzed loss of heterozygosity (LOH) on 11q13 (PYGM, INT-2) in atypical ductal hyperplasia (ADH) and various histological types of in situ carcinomas of the breast in patients without invasive cancer. Twenty-four cases of in situ carcinoma and twelve cases of ADH were studied. Tissue microdissection of normal, hyperplastic, and tumor cells from fixed, paraffin-embedded sections was performed, and DNA was extracted for polymerase chain reaction. In situ tumors included both high- and low-grade DCIS. LOH was identified in six of twenty-two (27.3%) in situ tumors and in one of eleven (9%) ADH cases. Within in situ carcinomas, LOH was identified in six of seventeen (35%) high-grade DCIS but in none of six low-grade DCIS. The present results show that LOH at 11q13 occurs in an appreciable proportion of high-grade DCIS, although the rate is substantially less than in patients with concomitant DCIS and invasive tumor. LOH was identified less frequently in low-grade in situ tumors and ADH, suggesting that a putative tumor suppressor gene(s) located on chromosome 11q13 may be involved in the transition from early preneoplastic lesions to invasive breast cancer. 相似文献
87.
H Zhuang A G Coulepis S A Locarnini J Kaldor J A Marshall I D Gust 《Journal of medical virology》1983,11(4):267-276
During a search for the aetiological agent of non-A non-B hepatitis, a precipitating antigen was detected in the sera of some patients during the acute phase of their illness. The antigen was detected by agar gel diffusion using antibody from convalescent sera obtained from patients with non-A non-B hepatitis, and from haemophiliac sera. The antigen was usually detected early in the patient's illness, disappearing as liver function tests returned to normal. In some patients specific antibody appeared during the convalescent phase of the disease. The antigen does not appear to be specific for non-A non-B hepatitis, as it could be detected with similar frequency in patients with hepatitis A or hepatitis B and some patients with other liver disorders. Biochemical and biophysical studies suggest that the antigen is probably an abnormal lipoprotein produced as a result of acute liver damage. 相似文献
88.
Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population 总被引:17,自引:0,他引:17
Hu N Roth MJ Polymeropolous M Tang ZZ Emmert-Buck MR Wang QH Goldstein AM Feng SS Dawsey SM Ding T Zhuang ZP Han XY Ried T Giffen C Taylor PR 《Genes, chromosomes & cancer》2000,27(3):217-228
Esophageal cancer is one of the most common fatal cancers worldwide. Deletions of genomic regions are thought to be important in esophageal carcinogenesis. We conducted a genomewide scan for regions of allelic loss using microdissected DNA from 11 esophageal squamous-cell carcinoma patients with a family history of upper gastrointestinal tract cancer from a high-risk region in north central China. Allelic patterns of 366 fluorescently labeled microsatellite markers distributed at 10-cM intervals over the 22 autosomal chromosomes were examined. We identified 14 regions with very high frequency (>/= 75%) loss of heterozygosity (LOH), including broad regions encompassing whole chromosome arms (on 3p, 5q, 9p, 9q, and 13q), regions of intermediate size (on 2q, 4p, 11p, and 15q), and more discrete regions identified by very high frequency LOH for a single marker (on 4q, 6q, 8p, 14q, and 17p). Among these 14 regions were 7 not previously described in esophageal squamous-cell carcinoma as having very high frequency LOH (on 2q, 4p, 4q, 6q, 8p, 14q, and 15q). The very high frequency LOH regions identified here may point to major susceptibility genes, including potential tumor suppressor genes and inherited gene loci, which will assist in understanding the molecular events involved in esophageal carcinogenesis and may help in the development of markers for genetic susceptibility testing and screening for the early detection of this cancer. Genes Chromosomes Cancer 27:217-228, 2000. Published 2000 Wiley-Liss, Inc. 相似文献
89.
Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: comparison with results of other viral markers 总被引:1,自引:0,他引:1
A capture enzyme-enhanced chemiluminescence immunoassay (ECLIA) based on three specific monoclonal antibodies to detect the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in the serial serum samples from SARS patients was developed. The anti-SARS-CoV IgG and the viral RNA were also detected in the sera by ELISA and RT-PCR, respectively. During the first 10 days after onset, anti-SARS-CoV IgG, SARS-CoV RNA and the N protein were detected in 21.4, 42.9, and 90% of the patients’ sera, respectively. The detection rate of the N protein during days 11–15 of the disease was still significantly higher than those of anti-SARS-CoV IgG and SARS-CoV RNA. The data demonstrated that detection of the N protein with the capture ECLIA appears to be more useful than detection of other viral makers for rapid diagnosis of SARS in patients. 相似文献
90.
血脂测定结果的临床可接受性分析 总被引:3,自引:2,他引:3
目的:通过对不同检测系统血脂测定结果的偏倚评估,分析各系统间结果的可比性和临床可接受性。方法:参照CLSI文件相关要求,以可溯源的检测系统为目标检测系统,测定总胆固醇(TCH)、甘油三酯(TG)、载脂蛋白A1(APOA1)、载脂蛋白B(APOB)、高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C),对本院3个不同检测系统进行朗道质控物(水平2和水平3)各测定21次和测定新鲜血清标本40份。结果:朗道质控物和新鲜血清标本TCH、TG、APOA1、APOB、HDL-C、LDL-C浓度在系统间的差异均有显著性(P<0.05)。除LDL-C在各检测系统间的相关系数为0.7859~0.9259之间外,其他项目各系统间的相关系数均大于0.975。各检测系统测定TCH、TG的不精密度CV均小于5%,其他项目的不精密度CV均小于10%;以可溯源检测系统1为目标检测系统,临床可接受性能评价:TCH、LDL-C在检测系统2和检测系统3超出临床接受范围,HDL-C在检测系统2超出临床接受范围,其他项目临床均可接受。结论:3个不同检测系统测定TG、APOA1、APOB结果具有可比性;测定HDL-C结果具有部分可比性,TCH、LDL-C结果不具有可比性,需采取整改措施。 相似文献